Qingguo Lai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Qingguo Lai has a total of 94 co-authors. Here are the top co-authors by number of shared publications:
Hongyu Xing
10 shared publicationsHongyu Zhao
8 shared publicationsRunqi Xue
Center of Stomatological, The Second Hospital, Cheeloo College of Medicine, Shandong University, 250033, PR China; Jinan Key Laboratory of Oral Materials, Jinan, 250033, PR China
8 shared publicationsYixuan Zhao
Center of Stomatological, The Second Qilu Hospital of Shandong University, Jinan, Shandong, 250012, China
6 shared publicationsYanwei Deng
Department of Oral and Maxillofacial Surgery, the Second Hospital of Shandong University, Jinan, China
5 shared publications- Bin Zou
Center for Advanced Jet Engineering Technologies (CaJET), School of Mechanical Engineering, Shandong University, Jinan 250061, China
4 shared publications
Latest Publications
- 28 October 2026
- Published by Wiley in Advanced Healthcare Materials
Self‐Crosslinked Oxidized Xyloglucan Hydrogels Enhance Macrophage Metabolism for Diabetic Wound Healing via the cAMP‐PKA Pathway
Xyloglucan, an immunomodulatory hemicellulose, shows potential for promoting chronic wound healing. However, tunable hydrogels composed solely of xyloglucan with a defined anti‐inflammatory mechanism remain elusive. To address this, we developed a single‐component, inherently bioactive oxidized xyloglucan (OXG) hydrogel that integrates anti‐inflammatory functionality with extracellular matrix (ECM)‐mimetic properties. The hydrogel forms autonomously via dynamic hemiacetal crosslinking between aldehyde and hydroxyl groups on the OXG backbone, eliminating the need for exogenous crosslinkers or drug loading. This strategy enables OXG to function both as an immunomodulator and as a supportive scaffold, exhibiting tissue adhesion, injectability, self‐healing, and stability in physiological environments. In vitro and in vivo results demonstrated that the OXG hydrogel promotes M2 macrophage polarization and suppresses pro‐inflammatory responses by activating the cAMP‐PKA signaling pathway, leading to a metabolic shift and inflammation resolution without exogenous cytokines. These actions collectively accelerated diabetic wound closure, enhanced angiogenesis, and facilitated orderly tissue regeneration. This work established a drug‐free hydrogel dressing with a well‐defined anti‐inflammatory mechanism by leveraging the inherent biological activity and self‐gelling capability of a single polysaccharide, achieving active remodeling of the immune environment in chronic diabetic wounds. These findings position OXG as a promising natural anti‐inflammatory biomaterial for tissue engineering and therapeutics.
- 28 October 2026
- Published by Wiley in Advanced Healthcare Materials
Self‐Crosslinked Oxidized Xyloglucan Hydrogels Enhance Macrophage Metabolism for Diabetic Wound Healing via the cAMP‐PKA Pathway
Xyloglucan, an immunomodulatory hemicellulose, shows potential for promoting chronic wound healing. However, tunable hydrogels composed solely of xyloglucan with a defined anti‐inflammatory mechanism remain elusive. To address this, we developed a single‐component, inherently bioactive oxidized xyloglucan (OXG) hydrogel that integrates anti‐inflammatory functionality with extracellular matrix (ECM)‐mimetic properties. The hydrogel forms autonomously via dynamic hemiacetal crosslinking between aldehyde and hydroxyl groups on the OXG backbone, eliminating the need for exogenous crosslinkers or drug loading. This strategy enables OXG to function both as an immunomodulator and as a supportive scaffold, exhibiting tissue adhesion, injectability, self‐healing, and stability in physiological environments. In vitro and in vivo results demonstrated that the OXG hydrogel promotes M2 macrophage polarization and suppresses pro‐inflammatory responses by activating the cAMP‐PKA signaling pathway, leading to a metabolic shift and inflammation resolution without exogenous cytokines. These actions collectively accelerated diabetic wound closure, enhanced angiogenesis, and facilitated orderly tissue regeneration. This work established a drug‐free hydrogel dressing with a well‐defined anti‐inflammatory mechanism by leveraging the inherent biological activity and self‐gelling capability of a single polysaccharide, achieving active remodeling of the immune environment in chronic diabetic wounds. These findings position OXG as a promising natural anti‐inflammatory biomaterial for tissue engineering and therapeutics.
- Open Access
- 29 September 2026
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (40) , e71787
A Dynamic Polysaccharide Hydrogel With Reactive Oxygen Species‐Scavenging, Antibacterial Activity, and Angiogenesis for Pressure Injury and Diabetic Wound Healing
Chronic wound healing is often delayed due to the inability of conventional dressings to provide a suitable extracellular matrix (ECM) microenvironment that supports the survival and function of endogenous cells. This deficiency leads to persistent inflammation, impaired angiogenesis, and excessive reactive oxygen species (ROS) production, forming a vicious cycle to exacerbate tissue damage. Herein, we propose a dual‐crosslinked injectable dynamic polysaccharide hydrogel. Leveraging anti‐inflammatory oxidized xyloglucan, and carboxymethyl chitosan to construct a first dynamic network based on Schiff‐base chemistry, this biomimetic extracellular matrix mimics dynamic changes to promote cell proliferation and resolve inflammation. Furthermore, strontium ions with pro‐angiogenic activity and protocatechualdehyde with antioxidant activity serve as crosslinking points for the second dynamic network. This design ensures spatiotemporal alignment between material mechanics and therapeutic action, effectively disrupting the vicious cycle of persistent inflammation, oxidative stress, and impaired angiogenesis in chronic wounds. Additionally, this hydrogel possesses commendable self‐healing, tissue‐adhesive and antibacterial properties. RNA sequencing analysis revealed that the hydrogel interrupts the inflammatory cascade, modulates immune processes, and accelerates collagen deposition and angiogenesis, promoting chronic wound healing. Collectively, these findings establish a foundation for designing straightforward and multifunctional hydrogel dressings capable of accelerating chronic wound repair by establishing a regenerative microenvironment.
- 29 September 2026
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (40) , e71787
Open AccessA Dynamic Polysaccharide Hydrogel With Reactive Oxygen Species‐Scavenging, Antibacterial Activity, and Angiogenesis for Pressure Injury and Diabetic Wound Healing
Chronic wound healing is often delayed due to the inability of conventional dressings to provide a suitable extracellular matrix (ECM) microenvironment that supports the survival and function of endogenous cells. This deficiency leads to persistent inflammation, impaired angiogenesis, and excessive reactive oxygen species (ROS) production, forming a vicious cycle to exacerbate tissue damage. Herein, we propose a dual‐crosslinked injectable dynamic polysaccharide hydrogel. Leveraging anti‐inflammatory oxidized xyloglucan, and carboxymethyl chitosan to construct a first dynamic network based on Schiff‐base chemistry, this biomimetic extracellular matrix mimics dynamic changes to promote cell proliferation and resolve inflammation. Furthermore, strontium ions with pro‐angiogenic activity and protocatechualdehyde with antioxidant activity serve as crosslinking points for the second dynamic network. This design ensures spatiotemporal alignment between material mechanics and therapeutic action, effectively disrupting the vicious cycle of persistent inflammation, oxidative stress, and impaired angiogenesis in chronic wounds. Additionally, this hydrogel possesses commendable self‐healing, tissue‐adhesive and antibacterial properties. RNA sequencing analysis revealed that the hydrogel interrupts the inflammatory cascade, modulates immune processes, and accelerates collagen deposition and angiogenesis, promoting chronic wound healing. Collectively, these findings establish a foundation for designing straightforward and multifunctional hydrogel dressings capable of accelerating chronic wound repair by establishing a regenerative microenvironment.
- Open Access
- 1 September 2026
- Published by KEAI Publishing in Bioactive Materials
- Vol. 63, 556-577
Spatiotemporally programming the immune-osteogenic cascade with a dual-immunomodulatory scaffold for functional bone regeneration
Functional repair of critical-sized bone defects is hindered by uncontrolled inflammatory microenvironments that disrupt endogenous regeneration. Conventional osteoimmunomodulatory biomaterials mainly emphasize direct regulating macrophage phenotype transformation, while neglecting the pivotal role of activating the immunomodulatory function of homing mesenchymal stem cells (MSCs) in immune-osteogenic cascade regulation. Herein, we present a dual-immunomodulatory bone scaffold (DIBS) to sequentially regulate the immune functions of macrophages and MSCs for repairing critical-sized bone defects. This scaffold integrates pH-responsive hydrogels containing oxidized xyloglucan (OXG) and metal polyphenol (Sr-PA) nanoparticles into a 3D-printed hydroxyapatite framework, enabling controlled release of immunomodulators and mineralization ions. The OXG first directs early M1-to-M2 macrophage transition to mitigate inflammation; then acidic-triggered release of Sr2+ and protocatechualdehyde from nanoparticles enhances the immunoregulatory function of homing MSCs. Additionally, hydroxyapatite framework provides essential mechanical stability and ion sources for late-stage osteogenic mineralization. Single-cell RNA sequencing and validation demonstrate that DIBS effectively induces the generation of immunoregulatory MSC subpopulations, which is associated with M2 macrophage activation through CCL2/CCR2 signaling axis, promoting angiogenesis and osteogenic differentiation. In vivo, DIBS effectively remodels the osteoimmune microenvironment, induces organized collagen arrangement and H-type vascularization, facilitating functional bone tissue repair. This study provides a new multicellular immunomodulatory strategy for endogenous bone repair.
- 1 September 2026
- Published by KEAI Publishing in Bioactive Materials
- Vol. 63, 556-577
Open AccessSpatiotemporally programming the immune-osteogenic cascade with a dual-immunomodulatory scaffold for functional bone regeneration
Functional repair of critical-sized bone defects is hindered by uncontrolled inflammatory microenvironments that disrupt endogenous regeneration. Conventional osteoimmunomodulatory biomaterials mainly emphasize direct regulating macrophage phenotype transformation, while neglecting the pivotal role of activating the immunomodulatory function of homing mesenchymal stem cells (MSCs) in immune-osteogenic cascade regulation. Herein, we present a dual-immunomodulatory bone scaffold (DIBS) to sequentially regulate the immune functions of macrophages and MSCs for repairing critical-sized bone defects. This scaffold integrates pH-responsive hydrogels containing oxidized xyloglucan (OXG) and metal polyphenol (Sr-PA) nanoparticles into a 3D-printed hydroxyapatite framework, enabling controlled release of immunomodulators and mineralization ions. The OXG first directs early M1-to-M2 macrophage transition to mitigate inflammation; then acidic-triggered release of Sr2+ and protocatechualdehyde from nanoparticles enhances the immunoregulatory function of homing MSCs. Additionally, hydroxyapatite framework provides essential mechanical stability and ion sources for late-stage osteogenic mineralization. Single-cell RNA sequencing and validation demonstrate that DIBS effectively induces the generation of immunoregulatory MSC subpopulations, which is associated with M2 macrophage activation through CCL2/CCR2 signaling axis, promoting angiogenesis and osteogenic differentiation. In vivo, DIBS effectively remodels the osteoimmune microenvironment, induces organized collagen arrangement and H-type vascularization, facilitating functional bone tissue repair. This study provides a new multicellular immunomodulatory strategy for endogenous bone repair.
- 29 November 2025
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 181, 214629
A β-Si3N4/HA composite materials with biomimetic mineralized CaCO3 coating promote angiogenesis and bone regeneration through immunomodulation
- 29 November 2025
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 181, 214629
A β-Si3N4/HA composite materials with biomimetic mineralized CaCO3 coating promote angiogenesis and bone regeneration through immunomodulation
- 10 September 2025
- Published by Elsevier in Cellular Signalling
- Vol. 136, 112124
BCAR3 confers resistance to cisplatin in head and neck squamous cell carcinoma by sustaining TGF-β/SMAD signaling
- 10 September 2025
- Published by Elsevier in Cellular Signalling
- Vol. 136, 112124
BCAR3 confers resistance to cisplatin in head and neck squamous cell carcinoma by sustaining TGF-β/SMAD signaling
- Open Access
- 1 July 2025
- Published by Tsinghua University Press in Journal of Advanced Ceramics
- Vol. 14 (7)
Additive manufacturing of graphene oxide-doped SiOC/Si 3N 4 photothermal functional bioceramic scaffolds through stereolithography technology
Clinical photothermal therapy for preventing bone tumor recurrence faces dual challenges: systemic toxicity risks from intravenous photosensitizer delivery and insufficient control of photothermal specificity. To address these limitations, we developed a stereolithography (SLA)-based additive manufacturing system for fabricating graphene oxide (GO)-reinforced SiOC/Si3N4 bioceramic scaffolds that integrate three functional components: a mechanically robust Si3N4 matrix, photothermally active SiOC, and osteoinductive GO. Initially, the polysiloxane KH570-H was synthesized, functioning as both a SiOC precursor and a photosensitive polymer, and subsequently formulated with 0-0.8 wt% GO/Si3N4 to develop SLA-compatible ceramic slurries. To address GO-induced light scattering defects, a GO content-photosensitive parameters predictive model was established, improving the dimensional accuracy of printed green bodies by 12.5% compared to non-optimized counterparts. Following sintering post-treatment, 0-0.8 wt% GO/SiOC/Si3N4 composite ceramics were fabricated, with the 0.2 wt% GO variant sintered at 1,300oC demonstrating optimal multifunctional performance. The compressive strength of the Gyroid unit TPMS scaffold with a porosity of 60% reached 41.88 MPa. Notably, the 0.2 wt% GO formulation showed superior cell proliferative capacity, as evidenced by fluorescence microscopy observations of confluent cell monolayers with extensive pseudopodial extensions, indicative of active osteogenic interactions. Under 808 nm near-infrared irradiation (1 W/cm²), the scaffold achieved rapid photothermal activation, reaching the therapeutic threshold of 47.8°C within 10 minutes in a physiomimetic microenvironment. This photothermally functional GO/SiOC/Si3N4 scaffold offers a promising dual-functional solution for post-tumor bone regeneration, combining structural adaptability with spatiotemporally controlled therapeutic precision.
- 1 July 2025
- Published by Tsinghua University Press in Journal of Advanced Ceramics
- Vol. 14 (7)
Open AccessAdditive manufacturing of graphene oxide-doped SiOC/Si 3N 4 photothermal functional bioceramic scaffolds through stereolithography technology
Clinical photothermal therapy for preventing bone tumor recurrence faces dual challenges: systemic toxicity risks from intravenous photosensitizer delivery and insufficient control of photothermal specificity. To address these limitations, we developed a stereolithography (SLA)-based additive manufacturing system for fabricating graphene oxide (GO)-reinforced SiOC/Si3N4 bioceramic scaffolds that integrate three functional components: a mechanically robust Si3N4 matrix, photothermally active SiOC, and osteoinductive GO. Initially, the polysiloxane KH570-H was synthesized, functioning as both a SiOC precursor and a photosensitive polymer, and subsequently formulated with 0-0.8 wt% GO/Si3N4 to develop SLA-compatible ceramic slurries. To address GO-induced light scattering defects, a GO content-photosensitive parameters predictive model was established, improving the dimensional accuracy of printed green bodies by 12.5% compared to non-optimized counterparts. Following sintering post-treatment, 0-0.8 wt% GO/SiOC/Si3N4 composite ceramics were fabricated, with the 0.2 wt% GO variant sintered at 1,300oC demonstrating optimal multifunctional performance. The compressive strength of the Gyroid unit TPMS scaffold with a porosity of 60% reached 41.88 MPa. Notably, the 0.2 wt% GO formulation showed superior cell proliferative capacity, as evidenced by fluorescence microscopy observations of confluent cell monolayers with extensive pseudopodial extensions, indicative of active osteogenic interactions. Under 808 nm near-infrared irradiation (1 W/cm²), the scaffold achieved rapid photothermal activation, reaching the therapeutic threshold of 47.8°C within 10 minutes in a physiomimetic microenvironment. This photothermally functional GO/SiOC/Si3N4 scaffold offers a promising dual-functional solution for post-tumor bone regeneration, combining structural adaptability with spatiotemporally controlled therapeutic precision.
- Open Access
- 20 March 2025
- Published by IOP Publishing in Biofabrication
- Vol. 17 (2) , 025028
Graphene oxide and in-situ carbon reinforced hydroxyapatite scaffolds via ultraviolet-curing 3D printing technology with high osteoinductivity for bone regeneration
Ultraviolet photopolymerization additive manufacturing has been used to fabricate calcium phosphate (Ca-P) ceramic scaffolds for repairing bone defects, but it is still a challenge for 3D printed Ca-P scaffolds to simultaneously enhance the mechanical strength and osteoinductivity. Here, we successfully developed a high-performance hydroxyapatite (HA) scaffold containing in-situ carbon and graphene oxide (GO) by precisely regulating the degreasing and sintering atmosphere. The results indicated that the mechanical properties of HA scaffolds could be significantly improved by regulating the amount of in-situ carbon. The HA scaffold containing 0.27 wt.% carbon achieved the maximum compressive strength of 12.5 MPa with a porosity of approximately 70%. The RNA transcriptome sequencing analysis revealed that in-situ carbon could promote osteogenic differentiation by improving oxygen transport and promoting the expression of multiple angiogenic factors. More importantly, in the absence of osteoinductive agents, the in-situ carbon and GO synergistically promoted more effective bone mineralization, demonstrating enhanced osteoinductivity in vitro. In a rodent model, the bioceramic scaffolds also exhibited improved osteogenesis in critical bone defects. Therefore, in-situ carbon and GO could simultaneously enhance the mechanical strength and osteoinductivity of HA scaffolds, effectively achieving substantial endogenous bone regeneration. This strategy will provide a simple and energy-efficient approach for engineering osteoinductive ceramic scaffolds for repairing bone defects.
- 20 March 2025
- Published by IOP Publishing in Biofabrication
- Vol. 17 (2) , 025028
Open AccessGraphene oxide and in-situ carbon reinforced hydroxyapatite scaffolds via ultraviolet-curing 3D printing technology with high osteoinductivity for bone regeneration
Ultraviolet photopolymerization additive manufacturing has been used to fabricate calcium phosphate (Ca-P) ceramic scaffolds for repairing bone defects, but it is still a challenge for 3D printed Ca-P scaffolds to simultaneously enhance the mechanical strength and osteoinductivity. Here, we successfully developed a high-performance hydroxyapatite (HA) scaffold containing in-situ carbon and graphene oxide (GO) by precisely regulating the degreasing and sintering atmosphere. The results indicated that the mechanical properties of HA scaffolds could be significantly improved by regulating the amount of in-situ carbon. The HA scaffold containing 0.27 wt.% carbon achieved the maximum compressive strength of 12.5 MPa with a porosity of approximately 70%. The RNA transcriptome sequencing analysis revealed that in-situ carbon could promote osteogenic differentiation by improving oxygen transport and promoting the expression of multiple angiogenic factors. More importantly, in the absence of osteoinductive agents, the in-situ carbon and GO synergistically promoted more effective bone mineralization, demonstrating enhanced osteoinductivity in vitro. In a rodent model, the bioceramic scaffolds also exhibited improved osteogenesis in critical bone defects. Therefore, in-situ carbon and GO could simultaneously enhance the mechanical strength and osteoinductivity of HA scaffolds, effectively achieving substantial endogenous bone regeneration. This strategy will provide a simple and energy-efficient approach for engineering osteoinductive ceramic scaffolds for repairing bone defects.
- Open Access
- 13 February 2025
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 23 (1) , 1-17
TNFAIP2 promotes NF-κB signaling mediate lymph node metastasis of oral squamous cell carcinoma by protecting IKKβ from ubiquitin proteasome degradation
Tumor dissemination is a life-threatening event which confers to most cancer-related deaths with limited effective therapeutic option. TNFα-induced protein 2 (TNFAIP2) reveals pro-metastasis potential in several cancers. However, its definite role and underlying mechanism in oral squamous cell carcinoma (OSCC) is largely unknown. The impact of TNFAIP2 on tumor metastasis was assessed based on the conditional knockout mouse with 4-nitroquinoline-1-oxide (4NQO) induced OSCC model through feature and immunohistochemistry analysis. To explore the specific mechanism, enrichment analysis and co-immunoprecipitation were applied. Meanwhile, the nano-hydroxyapatite (nHAp) and poly-L-lysine (PLL) based RNA interference delivery system was designed to restrict tumor dissemination. The conditional knockout Tnfaip2 in epithelium reduced tumor initiation rate, differentiation degree and cervical lymph node metastasis (LNM) in mouse exposed to 4NQO. Enrichment analysis suggested nuclear factor-kappa B (NF-κB) signaling was associated with these effects. Western blot proved that TNFAIP2 prevented the ubiquitin proteasome degradation of inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (IKKβ), a classical transcriptional activator protein in NF-κB signaling. Mechanistically, TNFAIP2 was demonstrated to competitively interact with kelch-like ECH-associated protein 1 (KEAP1) to avoid IKKβ from ubiquitination at K63 and proteasomal degradation subsequently, which finally sustained NF-κB signaling and facilitated tumor metastasis by enhancing epithelial-mesenchymal transition (EMT) and lymphangiogenesis. Notably, the synthetic small interfering RNA delivery systems nHAp@PLL-siTnfaip2 showed significant effect in attenuating tumor progression of OSCC mouse. Above results showed TNFAIP2 promoted EMT and lymphangiogenesis of OSCC by regulating NF-κB signaling, a mechanism that was dependent on the interaction with KEAP1 competitively. The nHAp based TNFAIP2 interference might serve as a novel therapeutic in limiting OSCC metastasis.
- 13 February 2025
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 23 (1) , 1-17
Open AccessTNFAIP2 promotes NF-κB signaling mediate lymph node metastasis of oral squamous cell carcinoma by protecting IKKβ from ubiquitin proteasome degradation
Tumor dissemination is a life-threatening event which confers to most cancer-related deaths with limited effective therapeutic option. TNFα-induced protein 2 (TNFAIP2) reveals pro-metastasis potential in several cancers. However, its definite role and underlying mechanism in oral squamous cell carcinoma (OSCC) is largely unknown. The impact of TNFAIP2 on tumor metastasis was assessed based on the conditional knockout mouse with 4-nitroquinoline-1-oxide (4NQO) induced OSCC model through feature and immunohistochemistry analysis. To explore the specific mechanism, enrichment analysis and co-immunoprecipitation were applied. Meanwhile, the nano-hydroxyapatite (nHAp) and poly-L-lysine (PLL) based RNA interference delivery system was designed to restrict tumor dissemination. The conditional knockout Tnfaip2 in epithelium reduced tumor initiation rate, differentiation degree and cervical lymph node metastasis (LNM) in mouse exposed to 4NQO. Enrichment analysis suggested nuclear factor-kappa B (NF-κB) signaling was associated with these effects. Western blot proved that TNFAIP2 prevented the ubiquitin proteasome degradation of inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (IKKβ), a classical transcriptional activator protein in NF-κB signaling. Mechanistically, TNFAIP2 was demonstrated to competitively interact with kelch-like ECH-associated protein 1 (KEAP1) to avoid IKKβ from ubiquitination at K63 and proteasomal degradation subsequently, which finally sustained NF-κB signaling and facilitated tumor metastasis by enhancing epithelial-mesenchymal transition (EMT) and lymphangiogenesis. Notably, the synthetic small interfering RNA delivery systems nHAp@PLL-siTnfaip2 showed significant effect in attenuating tumor progression of OSCC mouse. Above results showed TNFAIP2 promoted EMT and lymphangiogenesis of OSCC by regulating NF-κB signaling, a mechanism that was dependent on the interaction with KEAP1 competitively. The nHAp based TNFAIP2 interference might serve as a novel therapeutic in limiting OSCC metastasis.
- 14 January 2025
- Published by Elsevier in Journal of the Mechanical Behavior of Biomedical Materials
- Vol. 163, 106897
SLA-3D printing and bioactivity enhancement of zirconia anchor screws for temporomandibular joint disc reduction surgery
- 14 January 2025
- Published by Elsevier in Journal of the Mechanical Behavior of Biomedical Materials
- Vol. 163, 106897
SLA-3D printing and bioactivity enhancement of zirconia anchor screws for temporomandibular joint disc reduction surgery
- 7 November 2024
- Published by Elsevier in Ceramics International
- Vol. 51 (1) , 980-990
3D-printed laponite bioceramic triply periodic minimal surface scaffolds with excellent bioactivity for bone regeneration
- 7 November 2024
- Published by Elsevier in Ceramics International
- Vol. 51 (1) , 980-990
3D-printed laponite bioceramic triply periodic minimal surface scaffolds with excellent bioactivity for bone regeneration